"In a public advisory on Wednesday, Health Canada said that as interest grows in GLP-1 products for weight loss, "some people may turn to authorized or counterfeit products, which could pose serious health risks because they have not been assessed by Health Canada for safety, effectiveness, or quality." The versions of the medications authorized for use in Canada are semaglutide (Ozempic and Wegovy injections and Rybelsus oral tablets) and tirzepatide (Mounjaro and Zepbound injections)."
"Unauthorized or counterfeit drugs carry many risks, including: Containing too much, too little, or none of the active ingredient. Containing unlisted, dangerous or unknown ingredients. Containing contaminants, such as solvents, heavy metals, particles (fibers, glass, plastic), or microbials (bacteria, fungi, endotoxins). Being poorly or incorrectly labelled. Being improperly manufactured or stored."
"Unauthorized or counterfeit injectable products carry even more risks, such as infections due to lack of sterility, allergic reactions and other serious negative outcomes due to contamination, improper handling or unsafe administration, Health Canada said."
Health Canada warns consumers not to buy or use unauthorized or counterfeit GLP-1 medications, including fake semaglutide products. Authorized GLP-1 medications in Canada include semaglutide (Ozempic and Wegovy injections and Rybelsus oral tablets) and tirzepatide (Mounjaro and Zepbound injections). Unauthorized products have been identified in stores and online, sometimes using fake Health Canada logos and endorsements. Unauthorized or counterfeit drugs can contain incorrect amounts of active ingredient, unlisted or dangerous substances, contaminants, poor labeling, or be improperly manufactured or stored. Injectable counterfeits risk infections, allergic reactions and other serious harms. Selling such products or making false health claims is illegal.
Read at www.cbc.ca
Unable to calculate read time
Collection
[
|
...
]